News About: Pharm. Industry
CJ completes 150 billion GMP plant
CJ Cheil Jedang says it has completed construction on the 150-billion-won Osung Plant, North Chungcheong Province.
The plant's opening ceremony will be held on December 3 at Osung Life Science Complex, where the mi...
Kim named President of Handok Pharm
Kim Chul-joon, incumbent Vice President of Handok Pharm, has been named the new president, the company said Monday.
Kim, 56, served as a chief of R&D department from 2006, playing a key role in setting up the comp...
Market share of Korean firms likely to fall
Prospects have been grim for Korean firms, as they are getting pressed by multinationals' increasing market presence and the government's pressure to lower drug costs.
Generic drugs have long been the competitive ...
Lee Kwan-soon named as Hanmi’s president
Hanmi Pharmaceutical Co. Tuesday named Lee Kwan-soon, incumbent R&D chief as its new president.
The appointment comes after ex-president Lim Sun-min offered to resign due to poor performance in sales this year.
...
Hanmi sets eyes on European markets
Hanmi Pharmaceutical Co. is going all-out to make inroads into European countries as its clopidogrel drug has been recently approved by the Medicines Healthcare products Regulatory Agency (MHRA) in UK.
“We will ram...
Amway seeking to collaborate with Korean firms
Amway, the global direct selling giant, is striving to come up with a pair of products, possibly functional foods and cosmetics, based on Korea's cutting-edge technologies by 2012 under a scheme dubbed the “Open Innov...
License system for toll manufacturing medicines triggers debate
The government has approved the license of locally produced drugs by toll manufacturing, when an applicant without GMP facilities intends to make an application of new drugs which have not been available in Korea.
...
Rebate-taking doctors to face jail term
Starting from today, doctors and pharmacists who receive what are widely known as "rebates" from drug makers in return for prescribing or recommending their products will spend up to a year behind bars or have their l...
Foreign-invested pharmaceutical firms call for more tax exemptions for multinational clinical trials
Korea will have to seek to expand tax exemptions for multinational clinical trials as well as foreign corporate investment Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical ...
Dong-A Pharmaceutical names new execs in shake-up
Dong-A Pharmaceutical Co. says it has appointed Kang Jeong-seok, vice president and the forth son of incumbent Chairman Kang Shin-ho, as executive vice president to take charge of R&D functions in addition to overall ...
